Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5793358

COc1cc2c(C(=O)O)cnc(C(=O)c3cccc(OCC(=O)N(C)Cc4ccccc4)c3)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ GFPT1 Q06210 1/20 0.45
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ VNN1 O95497 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ NR1H2 P55055 1/20 0.37
▸ NR1H3 Q13133 1/20 0.37
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5745387 0.96 RAB9A (0.50) RAB9ANPC1SMN1; SMN2MAPK1GFPT1
SCHEMBL5744453 0.86 GFPT1 (0.44) RAB9ANPC1SMN1; SMN2GFPT1KMT2A
Trifluoroacetic Acid SCHEMBL5767994 0.86 GFPT1 (0.51) MAPK1GFPT1L3MBTL1VNN1NR1H2
SCHEMBL5745432 0.81 LMNA (0.48) SMN1; SMN2MAPK1GFPT1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL5767572 0.81 ALDH1A1 (0.50) SMN1; SMN2MAPK1GFPT1KMT2AMEN1
SCHEMBL5744619 0.81 GFPT1 (0.49) SMN1; SMN2MAPK1GFPT1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL5809778 0.80 GFPT1 (0.46) RAB9ANPC1SMN1; SMN2MAPK1GFPT1
Trifluoroacetic Acid SCHEMBL5768592 0.80 GFPT1 (0.63) GFPT1KMT2AMEN1L3MBTL1
Trifluoroacetic Acid SCHEMBL5763821 0.79 GAA (0.51) SMN1; SMN2MAPK1GFPT1KMT2AMEN1
SCHEMBL5744347 0.79 VNN1 (0.49) RAB9ANPC1SMN1; SMN2GFPT1VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631551-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 — — EP disclosed
WO-2004101528-A2 ISOQUINOLINE DERIVATIVES AND THEIR USE AS GFAT INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 — — WO disclosed
Send feedback